Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$0.43
+6.53%
Mkt Cap $111.20M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+133.9%
Consensus $1.00 vs current $0.43
NASDAQ·Healthcare·Biotechnology
$0.43
+6.53%
Mkt Cap $111.20M
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
+133.9%
Consensus $1.00 vs current $0.43